FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1602539968> ?p ?o ?g. }

• W1602539968 abstract "Background Virtual reality (VR) is computerised real‐time technology, which can be used an alternative assessment and treatment tool in the mental health field. Virtual reality may take different forms to simulate real‐life activities and support treatment. Objectives To investigate the effects of virtual reality to support treatment compliance in people with serious mental illness. Search methods We searched the Cochrane Schizophrenia Group Trials Register (most recent, 17th September 2013) and relevant reference lists. Selection criteria All relevant randomised studies comparing virtual reality with standard care for those with serious mental illnesses. We defined virtual reality as a computerised real‐time technology using graphics, sound and other sensory input, which creates the interactive computer‐mediated world as a therapeutic tool. Data collection and analysis All review authors independently selected studies and extracted data. For homogeneous dichotomous data the risk difference (RD) and the 95% confidence intervals (CI) were calculated on an intention‐to‐treat basis. For continuous data, we calculated mean differences (MD). We assessed risk of bias and created a 'Summary of findings' table using the GRADE approach. Main results We identified three short‐term trials (total of 156 participants, duration five to 12 weeks). Outcomes were prone to at least a moderate risk of overestimating positive effects. We found that virtual reality had little effects regarding compliance (3 RCTs, n = 156, RD loss to follow‐up 0.02 CI ‐0.08 to 0.12, low quality evidence), cognitive functioning (1 RCT, n = 27, MD average score on Cognistat 4.67 CI ‐1.76 to 11.10, low quality evidence), social skills (1 RCT, n = 64, MD average score on social problem solving SPSI‐R (Social Problem Solving Inventory ‐ Revised) ‐2.30 CI ‐8.13 to 3.53, low quality evidence), or acceptability of intervention (2 RCTs, n = 92, RD 0.05 CI ‐0.09 to 0.19, low quality evidence). There were no data reported on mental state, insight, behaviour, quality of life, costs, service utilisation, or adverse effects. Satisfaction with treatment ‐ measured using an un‐referenced scale ‐ and reported as interest in training was better for the virtual reality group (1 RCT, n = 64, MD 6.00 CI 1.39 to 10.61,low quality evidence). Authors' conclusions There is no clear good quality evidence for or against using virtual reality for treatment compliance among people with serious mental illness. If virtual reality is used, the experimental nature of the intervention should be clearly explained. High‐quality studies should be undertaken in this area to explore any effects of this novel intervention and variations of approach." @default.
• W1602539968 created "2016-06-24" @default.
• W1602539968 creator A5006270048 @default.
• W1602539968 creator A5010642595 @default.
• W1602539968 creator A5023017260 @default.
• W1602539968 creator A5048002345 @default.
• W1602539968 creator A5061514547 @default.
• W1602539968 creator A5061984001 @default.
• W1602539968 creator A5084836335 @default.
• W1602539968 creator A5085074957 @default.
• W1602539968 date "2014-10-08" @default.
• W1602539968 modified "2023-10-10" @default.
• W1602539968 title "Virtual reality for treatment compliance for people with serious mental illness" @default.
• W1602539968 cites W1591259115 @default.
• W1602539968 cites W166536261 @default.
• W1602539968 cites W1964162160 @default.
• W1602539968 cites W1965870443 @default.
• W1602539968 cites W1971738283 @default.
• W1602539968 cites W1977185679 @default.
• W1602539968 cites W1978040764 @default.
• W1602539968 cites W1978390032 @default.
• W1602539968 cites W1982178426 @default.
• W1602539968 cites W1986408549 @default.
• W1602539968 cites W1992557677 @default.
• W1602539968 cites W1992857340 @default.
• W1602539968 cites W1998013613 @default.
• W1602539968 cites W2001703021 @default.
• W1602539968 cites W2002111505 @default.
• W1602539968 cites W2003485059 @default.
• W1602539968 cites W2007629072 @default.
• W1602539968 cites W2014256646 @default.
• W1602539968 cites W2020844317 @default.
• W1602539968 cites W2023110482 @default.
• W1602539968 cites W2023781731 @default.
• W1602539968 cites W2023839473 @default.
• W1602539968 cites W2024522861 @default.
• W1602539968 cites W2030897682 @default.
• W1602539968 cites W2032712358 @default.
• W1602539968 cites W2045256980 @default.
• W1602539968 cites W2054348040 @default.
• W1602539968 cites W2058874144 @default.
• W1602539968 cites W2068811304 @default.
• W1602539968 cites W2069032643 @default.
• W1602539968 cites W2069139425 @default.
• W1602539968 cites W2076448873 @default.
• W1602539968 cites W2083366232 @default.
• W1602539968 cites W2084013825 @default.
• W1602539968 cites W2115058221 @default.
• W1602539968 cites W2119613840 @default.
• W1602539968 cites W2122154222 @default.
• W1602539968 cites W2125224312 @default.
• W1602539968 cites W2125392327 @default.
• W1602539968 cites W2125435699 @default.
• W1602539968 cites W2127079981 @default.
• W1602539968 cites W2127313266 @default.
• W1602539968 cites W2130235475 @default.
• W1602539968 cites W2135029321 @default.
• W1602539968 cites W2135675289 @default.
• W1602539968 cites W2135777012 @default.
• W1602539968 cites W2144575360 @default.
• W1602539968 cites W2150302132 @default.
• W1602539968 cites W2151736356 @default.
• W1602539968 cites W2152579596 @default.
• W1602539968 cites W2157823046 @default.
• W1602539968 cites W2166927254 @default.
• W1602539968 cites W2944275494 @default.
• W1602539968 cites W3000334409 @default.
• W1602539968 cites W4205195518 @default.
• W1602539968 cites W4211122169 @default.
• W1602539968 cites W4237433631 @default.
• W1602539968 cites W4246309853 @default.
• W1602539968 cites W4320288061 @default.
• W1602539968 cites W4375297255 @default.
• W1602539968 cites W4379093152 @default.
• W1602539968 cites W2063018731 @default.
• W1602539968 doi "https://doi.org/10.1002/14651858.cd009928.pub2" @default.
• W1602539968 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8078301" @default.
• W1602539968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25300174" @default.
• W1602539968 hasPublicationYear "2014" @default.
• W1602539968 type Work @default.
• W1602539968 sameAs 1602539968 @default.
• W1602539968 citedByCount "24" @default.
• W1602539968 countsByYear W16025399682015 @default.
• W1602539968 countsByYear W16025399682016 @default.
• W1602539968 countsByYear W16025399682017 @default.
• W1602539968 countsByYear W16025399682018 @default.
• W1602539968 countsByYear W16025399682019 @default.
• W1602539968 countsByYear W16025399682020 @default.
• W1602539968 countsByYear W16025399682021 @default.
• W1602539968 countsByYear W16025399682022 @default.
• W1602539968 countsByYear W16025399682023 @default.
• W1602539968 crossrefType "journal-article" @default.
• W1602539968 hasAuthorship W1602539968A5006270048 @default.
• W1602539968 hasAuthorship W1602539968A5010642595 @default.
• W1602539968 hasAuthorship W1602539968A5023017260 @default.
• W1602539968 hasAuthorship W1602539968A5048002345 @default.
• W1602539968 hasAuthorship W1602539968A5061514547 @default.
• W1602539968 hasAuthorship W1602539968A5061984001 @default.
• W1602539968 hasAuthorship W1602539968A5084836335 @default.
• W1602539968 hasAuthorship W1602539968A5085074957 @default.

• next